Effects of cilostazol and -lipoic acid on diabetic peripheral neuropathy
Some researchers report visible improvements in skin texture and hydration within 46 weeks
Cilofexor, a Nonsteroidal FXR Agonist, in Non-Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial
If longer-acting injections prove to be safe and effective in larger studies, they could make treatment easier for many patients
Regional Analysis North America Leading the GLP-1 Receptor Agonist Market North America accounted for the largest revenue share of 49.7% , supported by the high prevalence of type 2 diabetes and obesity, a developed healthcare system, and favorable reimbursement structures
There is no specific antidote to semaglutide, so treatment focuses on supportive care: IV fluids to reverse dehydration, anti-nausea medications, and continuous monitoring of blood sugar and heart rhythm